Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2− Early-stage Breast Cancer-Reference-Cited by-同舟云学术

Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2− Early-stage Breast Cancer

Published:2018-12 Issue:6 Volume:18 Page:474-480
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Kuwayama Takashi,Nakamura Seigo,Hayashi Naoki,Takano Toshimi,Tsugawa Koichiro,Sato Takanobu^ORCID,Kitani Akira^ORCID,Okuyama Hiromi,Yamauchi Hideko

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference12 articles.

1. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

2. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2003

3. Preoperative chemotherapy for women with operable breast cancer;Mieog;Cochrane Database Syst Rev,2007

4. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012

5. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review;Nano TransMed;2024-12

2. Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer;Nanomedicine: Nanotechnology, Biology and Medicine;2023-11

3. A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy;Pharmaceutics;2023-03-11

4. Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study;The Oncologist;2022-11-25

5. Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis;Annals of Palliative Medicine;2022-07